14 related articles for article (PubMed ID: 5370058)
1. In vitro evaluation of two controlled release propoxyphene hydrochloride formulations. Influence of the composition of dissolution media on drug release.
Baggesen S; Bechgaard H
Pharm Acta Helv; 1980; 55(11-12):312-5. PubMed ID: 7208533
[No Abstract] [Full Text] [Related]
2. Strength of the insoluble residues of plastic matrix slow release tablets (Duretter) in vitro and in vivo.
Dahlinder LE; Graffner C; Sjögren J
Acta Pharm Suec; 1973 Sep; 10(4):323-32. PubMed ID: 4759357
[No Abstract] [Full Text] [Related]
3. Propoxyphene and norpropoxyphene: influence of type of controlled-release formulation on intra- and intersubject variations.
Bechgaard H; Baggesen S
J Pharm Sci; 1980 Nov; 69(11):1327-30. PubMed ID: 7452465
[TBL] [Abstract][Full Text] [Related]
4. [The analgetic effect of dextropropoxyphene in a delayed-action form (Abalgin Retard)].
Kryger J; Aggerbeck B
Ugeskr Laeger; 1968 Jun; 130(24):1014-7. PubMed ID: 5686824
[No Abstract] [Full Text] [Related]
5. Mathematical model for in vitro drug release from controlled release dosage forms applied to propoxyphene hydrochloride pellets.
Christensen FN; Hansen FY; Bechgaard H
J Pharm Sci; 1982 Jun; 71(6):694-9. PubMed ID: 7097537
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo investigations of a new timed-release dosage form of propoxyphene hydrochloride.
Andersen HO; Christensen HH
Dan Tidsskr Farm; 1969; 43(6):117-26. PubMed ID: 5370058
[No Abstract] [Full Text] [Related]
7.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
